{"id":"https://genegraph.clinicalgenome.org/r/3fdc41cf-8a50-4817-a553-e0098eb522adv1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *NDUFV2* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of December 4, 2023. The *NDUFV2* gene encodes the NADH:ubiquinone oxidoreductase (complex I) flavoprotein 2, a core subunit of mitochondrial complex I. Defects of this protein lead to complex I deficiency. \n\n*NDUFV2* was first reported in relation to autosomal recessive primary mitochondrial disease in 2003 (PMID: 12754703), in a proband with hypertrophic cardiomyopathy, encephalopathy, feeding difficulty, and growth failure who died at three months of age. While various names could be given to the constellation of features seen in those with *NDUFV2*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *NDUFV2* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Of note, *NDUFV2* was previously curated by this GCEP on November 20, 2019 (SOP Version 7) as having a Limited association with Leigh Syndrome Spectrum (LSS). The scope of this current curation encompassed cases of primary mitochondrial disease, which includes LSS.   \n\nEvidence supporting the gene-disease relationship between *NDUFV2* and primary mitochondrial disease includes case-level data and experimental data. This curation includes nine unique variants in ten probands from nine publications (PMIDs: 12754703, 19167255, 26008862, 33811136, 34405929, 28429146, 30369941, 34276053, 30831263). Variant types included five missense, one frameshift, one stop-gain, one intragenic deletion and one recurrent splice region variant (NM_021074.5:c.120+5_120+8del). Affected individuals present with a broad phenotypic spectrum of generally severe disease which includes LSS. Clinical features include developmental regression, seizures, progressive spasticity, microcephaly, hypotonia, hypertrophic cardiomyopathy, optic atrophy, feeding difficulty, and failure to thrive. The age of onset ranges from birth to early infancy. Loss of function is implicated as the mechanism of disease. \n\nThis gene-disease association is also supported by known biochemical function and a C. elegans model system (PMIDs: 33340416. 19672299). \n\nIn summary, there is Definitive evidence to support this gene-disease relationship, including that more than three years have elapsed from the first proposal of the association. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on December 4, 2023 (SOP Version 9). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3fdc41cf-8a50-4817-a553-e0098eb522ad","GCISnapshot":"https://genegraph.clinicalgenome.org/r/0a5b5d66-4640-48a8-ac99-842593bac366","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/0a5b5d66-4640-48a8-ac99-842593bac366_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2024-01-22T16:00:33.938Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/0a5b5d66-4640-48a8-ac99-842593bac366_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2023-12-04T05:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a5b5d66-4640-48a8-ac99-842593bac366_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdd11c0a-d04f-4ecf-ac62-55a3163f29ec_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ead5b291-e441-43d1-b77d-af00ed8256f5","type":"EvidenceLine","dc:description":"LOF NMD expected 1.5 pt\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ead5b291-e441-43d1-b77d-af00ed8256f5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"exon 5/8","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/ead5b291-e441-43d1-b77d-af00ed8256f5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28429146","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3a0e643-3324-4f8d-94d2-91a06e9e3e91","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021074.5(NDUFV2):c.427C>T (p.Arg143Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8887215"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/eaaba60c-d0cd-450a-9b7b-c4697f3d0c2a","type":"EvidenceLine","dc:description":"Missense without impact","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eaaba60c-d0cd-450a-9b7b-c4697f3d0c2a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"reported in CH state in a second proband from Japan in PMID: 34405929 Kishita et al. 2021\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/eaaba60c-d0cd-450a-9b7b-c4697f3d0c2a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28429146","allele":{"id":"https://genegraph.clinicalgenome.org/r/9387f589-dc84-46a1-a8cd-5be6e48e1e53","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021074.5(NDUFV2):c.580G>A (p.Glu194Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA401858014"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/cdd11c0a-d04f-4ecf-ac62-55a3163f29ec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28429146","rdfs:label":"Ogawa 2017 Pt1177","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e3a0e643-3324-4f8d-94d2-91a06e9e3e91"},{"id":"https://genegraph.clinicalgenome.org/r/9387f589-dc84-46a1-a8cd-5be6e48e1e53"}],"detectionMethod":"genome screening","firstTestingMethod":"Other","phenotypeFreeText":"Leigh syndrome (diagnosed using criteria defined by Rahman)\nComplex I deficiency\nDevelopmental delay\nMRI) revealed high intensities in the brain stem (pons)\nBlood lactate and pyruvate were increased (7.23 and 0.26mmol/L; normal range <1.8 and <0.1mmol/L),\n","previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ead5b291-e441-43d1-b77d-af00ed8256f5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/eaaba60c-d0cd-450a-9b7b-c4697f3d0c2a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/94ad6ef0-c7a1-4d29-b0d1-c016e08c13b9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b07f57a-9877-4c84-96ac-091c272286fa","type":"EvidenceLine","dc:description":"confirmed splicing impact, exon 2 skipping results in reduced protein targeting to the mitochondria","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b07f57a-9877-4c84-96ac-091c272286fa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"see above, PMID:12754703 Benit et al. 2003\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5b07f57a-9877-4c84-96ac-091c272286fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30831263","allele":{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021074.5(NDUFV2):c.120+5_120+8del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8887112"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/94ad6ef0-c7a1-4d29-b0d1-c016e08c13b9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30831263","rdfs:label":"Nogueira 2019 P1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a"},"detectionMethod":"MT DNA and NGS panel of 209 mitochondrial genes","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Presented with Leigh syndrome, inclusion criteria/definition was not specified. \n","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5b07f57a-9877-4c84-96ac-091c272286fa_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/341edf0e-ad51-4906-8ac6-c785bda607b2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/925c5afd-d019-46ba-bc58-a3ac879f9da1","type":"EvidenceLine","dc:description":"F/S last exon, NMD not predicted, 10% truncation. Default reduced.\nScore 1 pt.\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/925c5afd-d019-46ba-bc58-a3ac879f9da1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"c.669_670insG, p.Ser224Valfs*3 (exon 8), last exon, NMD not expected but 10% truncation predicted.\nNo transcripts identified by RTPCR contained exon 8, suggesting NMD may occur.\nWestern blot: fibroblast lysate showed reduced NDUFV2 (25% of control protein). \n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/925c5afd-d019-46ba-bc58-a3ac879f9da1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26008862","allele":{"id":"https://genegraph.clinicalgenome.org/r/0b9c2223-ecc6-4894-ad31-9d715f78f864","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021074.5(NDUFV2):c.669_670insG (p.Ser224ValfsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8887311"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ff28b522-3d82-43e5-bc78-02674045aec0","type":"EvidenceLine","dc:description":"Recurrent splice region with support, see above. \nScore 1 pt.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff28b522-3d82-43e5-bc78-02674045aec0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"WB fibroblasts showed reduced NDUFV2 (25% of control protein). \nFunctional support, see above, Benit et al. 2003","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ff28b522-3d82-43e5-bc78-02674045aec0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26008862","allele":{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/341edf0e-ad51-4906-8ac6-c785bda607b2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26008862","rdfs:label":"Cameron 2015 Family 1 ","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":7,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/0b9c2223-ecc6-4894-ad31-9d715f78f864"},{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a"}],"detectionMethod":"WES Common mt-DNA variants also assessed. \n","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Jaundice, feeding issues, dehydration.\n11 weeks: cardiac arrest, echocardiography showed left-ventricular hypertrophic cardiomyopathy.  \nElevated lactate -28.5 mM (normal 2.5mM)\nMuscle histopathology: mild variation in fiber size, scattered atrophic fibers, no (RRF) or glycogen accumulation.\nEM: increased mitochondrial numbers, abnormal cristae. \nCT scan showed mild brain atrophy, no basal ganglia or thalamic changes.\nFH non consanguineous, sister: IUGR, and presented with neonatal lactic acidosis and hypertrophic cardiomyopathy on day 1 of life.\n","previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/925c5afd-d019-46ba-bc58-a3ac879f9da1_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ff28b522-3d82-43e5-bc78-02674045aec0_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/91504d1e-4d3c-41f3-967f-4449dc86aafd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4598e14-c761-4df4-aa8c-6cace92f84a1","type":"EvidenceLine","dc:description":"Missense w/o functional support (also reported in Ogawa et al. 2017)\nSecond allele: NC_000018.9:g.9122492_91244\n64delinsT[?] (GRCh37/Hg19)\nRNA seq detected aberrant splicing in patient fibroblast cells; exon skipping of exon\n5 predicted to cause a frameshift.\n\nLR Sequencing used to confirm phasing and presence of a  Alu‐mediated deletion encompassing intron 4, exon 5, and intron 5.\nWB confirmed reduced NDUFV2 expression and absence of transcript containing exon 5. \nPredicted LoF","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4598e14-c761-4df4-aa8c-6cace92f84a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34405929","allele":{"id":"https://genegraph.clinicalgenome.org/r/9387f589-dc84-46a1-a8cd-5be6e48e1e53"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/91504d1e-4d3c-41f3-967f-4449dc86aafd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34405929","rdfs:label":"Kishita 2021 Pt100","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9387f589-dc84-46a1-a8cd-5be6e48e1e53"},"detectionMethod":"Genomes sequencing\nRNA seq detected aberrant splicing in patient fibroblast cells; exon skipping of exon\n5 predicted to cause a frameshift.\nLR Sequencing used to confirm phasing and presence of a  Alu‐mediated deletion encompassing intron 4, exon 5, and intron 5.\n\n","firstTestingMethod":"Other","phenotypeFreeText":"Muscle tonus and regression of motor development from 8 months. Multiple infection induced episodic metabolic attacks lead to severe mental retardation and quadriplegia by 15 years.\nBrain MRI showed diffuse delayed myelination in the white matter.\nElevated lactate, blood: 4.92mmol/L [normal range < 1.8]; CSF: 4.04mmol/L [normal range < 2.3]\nBiochemistry: muscle tissue and skin fibroblast revealed isolated complex I deficiency.\nDied at 24 years.","previousTesting":true,"previousTestingDescription":"WES","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e4598e14-c761-4df4-aa8c-6cace92f84a1_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/60745477-510e-4be1-963d-8dfc51f437f2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0ea8761-97b2-4c3f-b095-95d9be917f48","type":"EvidenceLine","dc:description":"missense without functional impact","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0ea8761-97b2-4c3f-b095-95d9be917f48_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"same aa as Lui et al. 2022, p.Ala183Thr","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/d0ea8761-97b2-4c3f-b095-95d9be917f48_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276053","allele":{"id":"https://genegraph.clinicalgenome.org/r/056289bf-3ccd-4fe7-8650-4d132f786a1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021074.5(NDUFV2):c.548C>T (p.Ala183Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8887246"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/60745477-510e-4be1-963d-8dfc51f437f2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276053","rdfs:label":"Narayanan 2021 Family 4, III-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/056289bf-3ccd-4fe7-8650-4d132f786a1b"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Neuroregression and MRI brain showing leukoencephalopathy\n","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0ea8761-97b2-4c3f-b095-95d9be917f48_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/8481e36a-e464-4a3e-a770-29edb3731ec2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef5adef8-5564-4646-b225-3a986679e894","type":"EvidenceLine","dc:description":"Missense, no direct functional support, score 0.1 pt\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef5adef8-5564-4646-b225-3a986679e894_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Overexpression of wildtype NDUFV2 cDNA (lentiviral transduction) in CH patient fibroblasts rescued OCR (Fig 4). \n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/ef5adef8-5564-4646-b225-3a986679e894_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811136","allele":{"id":"https://genegraph.clinicalgenome.org/r/a6faa758-2223-4a61-b6e0-9e21052f487e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021074.5(NDUFV2):c.467T>A (p.Leu156His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA402024539"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1258b13d-8faf-4d45-92a6-fbeaa7f57550","type":"EvidenceLine","dc:description":"Missense, no direct functional support, score 0.1 pt","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1258b13d-8faf-4d45-92a6-fbeaa7f57550_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Overexpression of wildtype NDUFV2 cDNA (lentiviral transduction) in CH patient fibroblasts rescued OCR (Fig 4). \n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/1258b13d-8faf-4d45-92a6-fbeaa7f57550_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811136","allele":{"id":"https://genegraph.clinicalgenome.org/r/16f8f201-c016-4b1e-b81f-48351dba0a1f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021074.5(NDUFV2):c.404G>C (p.Cys135Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA402024406"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8481e36a-e464-4a3e-a770-29edb3731ec2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811136","rdfs:label":"Lui 2022 F2, II-1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/16f8f201-c016-4b1e-b81f-48351dba0a1f"},{"id":"https://genegraph.clinicalgenome.org/r/a6faa758-2223-4a61-b6e0-9e21052f487e"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Developmental arrest/delay from 4 months, hypertonia of both lower extremities.\nNormal lactate \nMRI showed a characteristic pattern of cystic changes in the deep\nperiventricular white matter. Diagnosed with leukoencephalopathy. \nFH: similarly affected brother.\n","previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1258b13d-8faf-4d45-92a6-fbeaa7f57550_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ef5adef8-5564-4646-b225-3a986679e894_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/58e62c6c-7ed6-4f13-9c72-5dd70ea9652c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1704c2a-5520-4764-9273-b1249652622a","type":"EvidenceLine","dc:description":"Recurrent splice region with support, see above. ","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1704c2a-5520-4764-9273-b1249652622a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Exon2 skipping confirmed in PMID:12754703, Benit et al. 2003. \nFunction: Liu et al. 2011 used a series of experiments in  HEK cells to demonstrate abnormal processing of the mutant transcript and a significant reduction in mitochondrial targeting, majority of protein is cytosolic.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a1704c2a-5520-4764-9273-b1249652622a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19167255","allele":{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/58e62c6c-7ed6-4f13-9c72-5dd70ea9652c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19167255","rdfs:label":"Pagniez-Mammeri 2009 Patient 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a"},"detectionMethod":"Variants in nuclear complex I genes, large mitochondrial DNA rearrangements and the common mitochondrial mutations (LHON G3460A, G11778A, T14484C; MELAS A3243G, T3271C; MERRF A8344G, T8356C; NARP T8993G, T8993C) were excluded. \n","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"hypertrophic cardiomyopathy and encephalopathy\nComplex I deficiency\n","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a1704c2a-5520-4764-9273-b1249652622a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f3e74f74-ae7b-45bb-a5f9-7c6973a1c0ea_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/058e82b7-7501-4dce-84b0-da673a75f6d7","type":"EvidenceLine","dc:description":"missense with impact support","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/058e82b7-7501-4dce-84b0-da673a75f6d7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"see 33811136: Lui et al. 2022 rescue in patient fibroblasts\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/058e82b7-7501-4dce-84b0-da673a75f6d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30369941","allele":{"id":"https://genegraph.clinicalgenome.org/r/0fcec1b9-6b99-4c46-b45a-00f3f0b82ec5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021074.5(NDUFV2):c.547G>A (p.Ala183Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA401856902"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/f3e74f74-ae7b-45bb-a5f9-7c6973a1c0ea","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30369941","rdfs:label":"Theunissen 2018 Paediatric patient","allele":{"id":"https://genegraph.clinicalgenome.org/r/0fcec1b9-6b99-4c46-b45a-00f3f0b82ec5"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Encephalopathy, white matter\nDegeneration.\nComplex I deficiency\n","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/058e82b7-7501-4dce-84b0-da673a75f6d7_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/28afb33b-50b2-44ba-8128-93feda57fbf3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7e8599a-ae38-4048-a674-f08274deb47b","type":"EvidenceLine","dc:description":"Recurrent splice region with upgraded support, see above. \n","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7e8599a-ae38-4048-a674-f08274deb47b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"see above PMID:12754703, Benit et al. 2003. \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a7e8599a-ae38-4048-a674-f08274deb47b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26008862","allele":{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/28afb33b-50b2-44ba-8128-93feda57fbf3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26008862","rdfs:label":"Cameron 2015 Family 2 ","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a"},"detectionMethod":"Candidate gene sequencing of NDUFV2 only","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Seizures onset at 2 months of age. Regression with progressive spasticity, nystagmus, optic atrophy and microcephaly was noted at 10 months of age. Progressive neurological deterioration. No cardiac involvement. Died at 10 years. \nCT at 11 months (Fig. 2b) and 15 months (Fig. 2c): progressive caudate and putaminal cavitation. CT scans at 2 years 7 months, and 5 years 9 months of age demonstrated persistence of basal ganglia changes and progressive brain atrophy. \nNeuroimaging (Figure 2): demonstrates progressive putaminal and caudate cavitation. Meets criteria for LSS. \nFibroblasts showed elevated lactate (table 1), complex I deficiency demonstrated in muscle biopsy from affected brother\nFH: consanguineous family, affected brother and affected sister\n","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a7e8599a-ae38-4048-a674-f08274deb47b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0a3e4265-6731-42bb-b300-a0fdfd1dfbbd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96146f70-9b1f-44b4-84f9-92a08cafa0ea","type":"EvidenceLine","dc:description":"Missense variant with functional support (rescue). ","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96146f70-9b1f-44b4-84f9-92a08cafa0ea_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Overexpression of WT cDNA (lentiviral transduction) in patient fibroblasts rescued OCR (Fig 4). \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/96146f70-9b1f-44b4-84f9-92a08cafa0ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811136","allele":{"id":"https://genegraph.clinicalgenome.org/r/0fcec1b9-6b99-4c46-b45a-00f3f0b82ec5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/0a3e4265-6731-42bb-b300-a0fdfd1dfbbd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811136","rdfs:label":"Lui 2022 F1, II-1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0fcec1b9-6b99-4c46-b45a-00f3f0b82ec5"},"detectionMethod":"Genome sequencing","firstTestingMethod":"Other","phenotypeFreeText":"14 months neurodevelopmental regression after fever.\nMRI showed a characteristic pattern of cystic changes in the corpus callosum and deep periventricular white matter. \nAt the age of 2 years, she could again walk alone. \n7 years and 2 months old, her neurological condition was stable, with slight infantile behaviour.\nIsolated complex I deficiency muscle and fibroblasts (Table 1).\n\nFH: Affected brother, similar course but second episode of neurological deterioration at 4 years, irritability, salivation, dysarthria, dysphagia,\ndystonia, developmental regression, strabismus and pyramidal\ntract impairment. MRI: diffuse cystic changes involving the cerebral hemispheric white matter and corpus callosum. Normal lactate levels. \n","previousTesting":true,"previousTestingDescription":"NGS panel 115 leukodystrophy genes","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/96146f70-9b1f-44b4-84f9-92a08cafa0ea_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/84b1eefd-65f0-4bdb-8a9f-c502c8cdf953_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a398d20-e5e9-4ec5-b088-6dd2fb870009","type":"EvidenceLine","dc:description":"Other variant with upgraded functional support (consistent with LSS curation).\n1 pt \n","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a398d20-e5e9-4ec5-b088-6dd2fb870009_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant reported as IVS2+5_+8delGTTA, 4 bp deletion within intron 2. Updated nomenclature: NM_021074.5:c.120+5_120+8del.\nRTPCR confirmed skipping of exon 2 (Fig1C), disrupts the mitochondrial targeting sequence. \nFunction: Liu et al. 2011 used a series of experiments in  HEK cells to demonstrate abnormal processing of the mutant transcript and a significant reduction in mitochondrial targeting, majority of protein is cytosolic.\n\nFibroblasts showed reduced NDUFV2, residual protein 33% and 25% of controls from Patients 1 and 2, respectively.\n\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0a398d20-e5e9-4ec5-b088-6dd2fb870009_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12754703","allele":{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/84b1eefd-65f0-4bdb-8a9f-c502c8cdf953","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12754703","rdfs:label":"Benit 2003 Patient 1","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/80d2c1b2-6da2-4c40-bbd7-dc826e18bb8a"},"detectionMethod":"DHPLC used to r/o: NDUFV1, NDUFS8, NDUFS7, NDUFB6, NDUFA8, NDUFS1, NDUFS2\n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Denaturing gradient gel","phenotypeFreeText":"Hypertrophic cardiomyopathy and truncal hypotonia. Feeding difficulties and growth retardation were noted at day 8. \nPersistent hyperlactatemia.\nProband died at 3 months.\nMuscle biopsy:50–60% complex I deficiency.\nEndomyocardial biopsy: 50% complex I deficiency.\nSkin fibroblasts: 50% complex I deficiency.\nFH: Consanguineous family; two younger brothers (Patients 2 and 3) subsequently died of hypertrophic cardiomyopathy in their first year of life.\n\n","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0a398d20-e5e9-4ec5-b088-6dd2fb870009_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/0a5b5d66-4640-48a8-ac99-842593bac366_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a5b5d66-4640-48a8-ac99-842593bac366_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/341c0266-21ac-45ec-889d-5f5f61237a79","type":"EvidenceLine","dc:description":"Biochemical recapitulation of disease (reduced complex I activity)\n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/09f2c1ae-3a4a-4e52-a638-af95f0c11f88","type":"Finding","dc:description":"C.elegans: RNAi knockdown (hypomorph)\nRNAi-generated hypomorphic C. elegans strains were generated for 28 nDNA-encoded complex I subunits and complex I assembly factors, strains were exposed for 3 generations to RNAi. \nData summarised in Table 3, the 51% RNAi knockdown lead to a 24% reduction in complex I activity in isolated mitochondria. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19672299","rdfs:label":"C.elegans RNAi knockdown","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0a5b5d66-4640-48a8-ac99-842593bac366_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de5d7d57-445e-4bcb-be2e-95c3e6d4d88d","type":"EvidenceLine","dc:description":"2 pt (>10+ genes with a shared function associated with PMD)\n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2d2eea8-0574-40a1-8d23-22ec79c770c9","type":"Finding","dc:description":"Other non-catalytic subunits of complex I have been associated with PMD","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33340416","rdfs:label":"Ferreira 2021 ICMD review","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":7599,"specifiedBy":"GeneValidityCriteria9","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/7uk-VswLJnA","type":"GeneValidityProposition","disease":"obo:MONDO_0044970","gene":"hgnc:7717","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_0a5b5d66-4640-48a8-ac99-842593bac366-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}